Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Opiant Pharmaceuticals Inc
(NQ:
OPNT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
20.80 (24)
Ask (Size)
24.99 (1)
Prev. Close
20.65
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
4,399,675
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio
March 03, 2023
Indivior PLC (OTCPK:INVVY) (LSE:INDV) has completed the acquisition of Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) The transaction strengthens Indivior's addiction treatment and science portfolio by...
Via
Benzinga
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
February 07, 2023
From
Opiant Pharmaceuticals, Inc.
Via
GlobeNewswire
Performance
More News
Read More
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
February 06, 2023
From
Opiant Pharmaceuticals, Inc.
Via
GlobeNewswire
Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose
January 19, 2023
From
Opiant Pharmaceuticals, Inc.
Via
GlobeNewswire
OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT
January 06, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Analyzing Opiant Pharma's Short Interest
January 03, 2023
Via
Benzinga
How Is The Market Feeling About Opiant Pharma?
December 08, 2022
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
December 05, 2022
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Via
Benzinga
Tesla, Amazon, Opiant, Nu, Paramount: Lawsuit, Earnings, Warren Buffett's Increased Stake Draw Investor Attention
November 14, 2022
Via
Benzinga
OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT
November 14, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Looking Into Opiant Pharma's Recent Short Interest
November 14, 2022
Via
Benzinga
Dow Surges 150 Points; Crude Oil Falls Sharply
November 14, 2022
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 14, 2022
Via
Benzinga
Opiant Pharmaceuticals (NASDAQ: OPNT) Enters Into Definitive Agreement to be Acquired by Indivior for $145 Million
November 14, 2022
Via
Spotlight Growth
Stocks Cool Off From Last Week's Rally
November 14, 2022
Via
Talk Markets
Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings
November 14, 2022
Via
Benzinga
Party City Layoffs 2022: What to Know About the PRTY Job Cuts
November 14, 2022
Via
InvestorPlace
Why Is Opiant Pharma (OPNT) Stock Up 116% Today?
November 14, 2022
Via
InvestorPlace
US Stocks Mostly Lower; Nasdaq Drops Over 100 Points
November 14, 2022
Via
Benzinga
OPNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Opiant Pharmaceuticals, Inc. Is Fair to Shareholders
November 14, 2022
From
Halper Sadeh LLC
Via
Business Wire
Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14
November 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 14, 2022
Via
Benzinga
Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals
November 14, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.